The questions people ask — answered plainly.

Generally no. Injectable amniotic, umbilical cord, Wharton's jelly and exosome products marketed for joints and tendons are not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's FDA status before treatment.

Amniotic doctors is a term people use for licensed clinicians who work with or discuss amniotic-based products. Amniotic Doctors is a directory that helps you find independent providers and educational resources. Listing does not mean endorsement, and each doctor decides what is appropriate for each patient.

Most do not contain living stem cells after processing. For that reason, they should not be called stem-cell treatments. Ask your provider how the product is sourced and processed.

There is no established basis for saying they regrow cartilage or tissue. Claims like that should be treated with caution. A licensed clinician can explain what is known and unknown about your injury and options.

Many people start with an orthopedic or sports medicine doctor or a physical medicine and rehabilitation physician. Some also consult regenerative medicine clinics for additional perspective. The right fit depends on your injury and goals.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also check with your insurance before treatment. A trustworthy provider should welcome these questions.

Several types of licensed providers care for back and spine pain, including primary care clinicians, spine care specialists and pain management doctors. Which one fits depends on your symptoms and history. Providers.plus lists licensed providers you can explore.

A pain management doctor evaluates the source of ongoing pain and discusses a range of options with you. These may include medicines, therapy referrals or procedures such as injections, depending on what the clinician finds appropriate. They do not promise any particular outcome.

Injection-based options are procedures in which a clinician delivers medicine near a spinal structure, often using imaging guidance. Corticosteroid and numbing medicine injections are examples that have been used traditionally. Ask your provider what is being injected, why, and what the risks and alternatives are.

No, amniotic injections for back and spine pain are generally not FDA-approved for those uses. Amniotic membrane's established uses are as a wound covering and on the eye surface. The FDA has warned the public about unapproved regenerative products, so ask a provider about the product's status, source, risks and total cost.

Most processed amniotic and umbilical cord products contain no living stem cells, and they should not be described as stem-cell treatments. They are not proven to regrow cartilage, discs or other tissue. Ask your provider for clear, honest information about what a product is and is not.

Write down when your pain began, what makes it better or worse, and what you have already tried. Bring any prior imaging or records and a list of your medicines. Also prepare questions about options, risks, alternatives, total cost and insurance coverage.

An amniotic membrane graft is a thin piece of processed, donated tissue from the amniotic sac that a clinician may place over certain wounds as a covering. Using amniotic membrane as a wound covering is an established use. Whether it fits your wound is a decision for a licensed provider after an evaluation.

Coverage varies by plan, product and the type of wound, so there is no single answer. Medical coverage often depends on the diagnosis, what standard care has already been tried, and the clinic's documentation. Ask your provider's office and your insurer about coverage and your total costs before treatment.

Wound care specialists and podiatrists commonly treat slow-healing wounds, and other licensed clinicians may be involved depending on the cause. Podiatrists focus on the feet and ankles, while wound care clinics see many wound types. A primary care provider can also help you find the right referral.

Injectable amniotic, umbilical cord, Wharton's jelly and exosome products marketed for joints, pain, hair, skin or regeneration are generally not FDA-approved for those uses. The FDA has warned the public about unapproved regenerative products. Ask any provider about a product's FDA status, tissue source, risks and alternatives.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing. They also should not be said to regrow tissue, and any provider describing them that way deserves further questions.

Ask what the product is, what its FDA status is, where the tissue comes from, and what the risks and alternatives are. Also ask what standard care has been tried, how progress will be tracked, and what the total cost is. Confirm insurance coverage before treatment begins.

Generally, no. Amniotic membrane is established as a wound covering and on the eye surface, but injectable amniotic products for joints, pain or similar uses are generally not FDA-approved for those purposes. Ask any provider about the specific product's FDA status.

PRP is made from your own blood, while amniotic and umbilical cord products come from donated birth tissue. Each is processed differently, and each has a different regulatory picture. A licensed clinician can explain which, if any, may be appropriate for you.

No, they shouldn't be described that way. Most amniotic and cord products contain no living stem cells after processing. If a clinic uses the term 'stem cell', ask exactly what the product contains and where it comes from.

There is no reliable basis to promise that. Claims of regrowing cartilage or tissue should be treated with caution. A doctor can explain what is and isn't known.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Check with your insurance beforehand, since many of these treatments may not be covered. Getting a second opinion is reasonable.

Regenerative medicine clinics and orthopedic and sports medicine doctors often discuss these options. You can look for licensed providers through Providers.plus. A good doctor will explain the evidence and your alternatives plainly.

Amniotic grafts are thin tissue coverings made from donated amniotic membrane that a wound care provider may place over a wound. Using amniotic membrane as a wound covering is an established use. Whether one is right for you is a decision for a licensed clinician after an evaluation.

No one can promise that a graft will heal a wound. Some providers use them as one part of a broader plan that also looks at pressure, circulation, infection and blood sugar management. Ask your provider what to realistically expect in your situation.

It depends on the product and the use, so ask your provider about the specific product's FDA status. Amniotic membrane as a wound covering is the established use, while injectable amniotic or umbilical cord products for joints, pain or regeneration are generally not FDA-approved for those uses. The FDA has warned the public about unapproved regenerative products.

Either may help, and many people see both as part of a care team. A podiatrist focuses on foot health, while a wound care provider focuses on wounds that are slow to heal. Your primary care doctor can also help point you to the right licensed provider.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing, and they are not known to regrow tissue. Ask your provider exactly what is in a product and where the tissue comes from.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also check with your insurance before treatment so there are no surprises. Your provider should be willing to explain each answer in plain language.

An amniotic eye doctor is a common search phrase for an eye doctor, usually an ophthalmologist, who uses amniotic membrane on the eye surface in suitable cases. It is not a separate specialty. Ask the doctor about their experience and whether it fits your situation.

It may be considered in certain cases, usually more severe or persistent surface problems, but it is not a first step for most people with dry eye. An eye doctor decides after an exam. Results vary and nothing is guaranteed.

Regulatory status depends on the specific product, so ask your provider about the FDA status of the exact product they plan to use. Amniotic membrane as a covering for the eye surface is the established use. Injectable amniotic or umbilical products for other purposes are generally not FDA-approved for those uses.

Experiences differ by product and by person, and your doctor can explain what to expect for your case. Some versions are placed with a ring or stitches, and others sit like a thin lens. Ask about comfort, how long it stays in, and follow-up visits.

It comes from donated placental tissue, collected with consent after a planned birth, then processed and preserved. Ask your provider about the tissue source and how the product was prepared and tested.

Ask why they think it fits your condition, which product they would use and its FDA status, the risks, the alternatives, and the total cost. Also check with your insurance before treatment so there are no surprises.

Generally no. Injectable amniotic, umbilical cord and Wharton's jelly products marketed for knee and joint pain are not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Ask any provider about a product's exact regulatory status before treatment.

Usually not living ones. Most amniotic products have no living stem cells after processing, so calling them stem-cell treatments is not accurate. A provider should be able to explain exactly what is in a product.

There is no established basis to say they regrow cartilage or other tissue, and you should be cautious of anyone who claims so. Research on these products for joints is still developing, and no result can be promised.

Amniotic membrane is well established as a wound covering and for use on the surface of the eye. That is different from injecting amniotic products into joints, which is generally not an FDA-approved use.

Orthopedics and sports medicine, pain management, and physical medicine and rehabilitation doctors often evaluate knee and joint pain. They can examine you, discuss possible causes, and talk through options, which may or may not include injections. You can look for licensed providers through Providers.plus.

Ask about the product's FDA status, its tissue source, the risks, the alternatives, and the total cost, and check with your insurance first. It is also reasonable to ask what the provider expects and what the limits of the evidence are, and to get a second opinion.

Amniotic treatments use tissue from the placenta or amniotic sac, which is donated and processed into different forms. The established uses are as a wound covering and on the surface of the eye. Other uses, such as injections for joints or pain, are generally not FDA-approved.

Coverage is often limited or unavailable for injectable amniotic products used for joints or pain, because they are generally not FDA-approved for those uses. Coverage can differ for wound care and depends on your plan and situation. Ask your provider's office and Medicare or your plan about coverage before any treatment.

Injectable amniotic, umbilical cord, Wharton's jelly and exosome products marketed for joints, pain, hair, skin or regeneration are generally not FDA-approved for those uses. The FDA has warned the public about unapproved regenerative products. Ask any provider about a product's exact FDA status.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing. Be wary of any claim that a product regrows cartilage or tissue.

Start by choosing a licensed clinician, such as an orthopedic, wound care or pain management doctor, and ask about their training and experience. Ask about the product's FDA status, tissue source, risks, alternatives and total cost. Providers.plus lists licensed providers, and your primary care doctor can also be a good source of referrals.

Caregivers can attend appointments, take notes, and help ask questions about risks, alternatives and costs. They can also help check insurance coverage and licensing before treatment. Taking time to decide, and getting a second opinion if you wish, is always reasonable.

Amniotic tissue is the membrane and fluid from the amniotic sac that surrounds a baby during pregnancy. It is usually donated with consent after a planned cesarean birth. It can then be screened, processed and used to make medical products.

An amniotic membrane allograft is a piece of donated, processed amniotic membrane used as a biological covering. Its established uses are on certain wounds and on the surface of the eye. A licensed clinician decides whether it is appropriate.

Generally, no. Amniotic fluid and other injectable amniotic products promoted for joints, pain, hair, skin or 'regeneration' are not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Ask your provider about a product's FDA status, risks and alternatives.

They come from donated placental tissue, typically collected after a planned cesarean delivery from a consenting, screened donor. The tissue is then processed, tested and preserved by a manufacturer. Ask a provider about the specific tissue source of any product.

Most do not contain living stem cells after processing. For that reason they should not be described as stem-cell treatments, and claims that they regrow cartilage or tissue should be treated with caution.

Start by looking for a licensed clinician, such as through Providers.plus, and ask about their experience and the product's FDA status. Ask about its tissue source, risks, alternatives and total cost, and check your insurance before treatment.

PRP is made from your own blood, while amniotic products come from donated placental tissue. Their regulatory status and processing differ, and both are discussed with a licensed provider rather than chosen on your own. Ask any provider what the product is, where it comes from and whether it is FDA-approved for the intended use.

No, not necessarily. Many products marketed as stem cell injections are processed amniotic or cord tissue, and most contain no living stem cells after processing. Ask the provider exactly what is in the product and how it was prepared.

Generally, no. Umbilical cord tissue and Wharton's jelly injections for joints, pain or regeneration are not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. A provider can explain the current status and the risks.

Generally, no. Exosome products marketed for pain, hair, skin or regeneration are not FDA-approved for those uses. Ask any provider about a product's FDA status, its source and the risks before treatment.

Cortisone is an established, FDA-regulated medicine, while injectable amniotic products are generally not FDA-approved for joint or pain uses. They are not interchangeable, and each has its own considerations. A licensed clinician can explain the options for your situation after an evaluation.

Start with a licensed provider, such as those listed on Providers.plus, and check their credentials. At a visit, ask about FDA status, tissue source, risks, alternatives, total cost and insurance. A second opinion is always reasonable.

Amniotic membrane for dry eye is donated placental tissue that an eye doctor may place on the eye surface as a protective covering. It is usually considered when other approaches have not been enough, and only after an exam. Whether it suits you is a decision for your eye doctor.

Regulation depends on the specific product and how it is made and labeled. Using amniotic membrane as a covering on the eye surface is an established practice. Ask your provider about the FDA status of the exact product they would use.

For a corneal ulcer, an eye surgeon may use amniotic membrane as a covering that protects the cornea while it heals. It is typically one part of a larger plan that also addresses the cause. A corneal ulcer can threaten vision, so see an eye doctor promptly.

Amniotic membrane dental use means some dentists and oral surgeons use the tissue as a covering during certain gum or oral procedures. Evidence and product regulation vary, and not every clinician uses it. Ask your provider why they recommend it, what the alternatives are, and what the product's FDA status is.

An amniotic membrane gum graft is one option some clinicians discuss, but it is not necessarily a replacement for other graft materials. The right choice depends on your mouth, your goals and your provider's experience. Ask about alternatives, risks and total cost, and check your insurance.

No, amniotic products should not be described as stem-cell treatments. Most are processed in ways that leave no living stem cells. Injectable amniotic or cord products for joints, pain or hair are generally not FDA-approved for those uses, so ask your provider about any product's status.

Generally, no. Injectable amniotic, umbilical cord and Wharton's jelly products marketed for joints, pain, hair, skin or regeneration are not FDA-approved for those uses. Amniotic membrane as a wound covering and on the eye surface is the established use. Ask your provider about the specific product's regulatory status.

The FDA has warned the public about unapproved regenerative products, including some amniotic and umbilical cord products promoted for conditions they have not been approved to treat. The concern is that claims may outpace evidence and that safety may not be well established. Ask a licensed provider about any product before agreeing to it.

Side effects depend on the product, the person and the injection site, and a licensed clinician can explain what applies to you. Injections in general can carry risks such as pain, swelling, infection or an unwanted reaction to the material. Because many of these products are unapproved, their risks may be less well understood, so ask about this directly.

Risks may include reactions to the product, infection, and the chance that it simply does not help. There is also the risk of paying out of pocket for something not covered by insurance. A provider can explain the risks and alternatives for your situation after an evaluation.

Ask whether the product is FDA-approved for your use, where the tissue came from, and which tissue bank processed it. Also ask about risks, alternatives, expected follow-up and the total cost, and check your insurance first. A good provider will answer plainly and give you time to decide.

No, this is a common myth. Most amniotic products contain no living stem cells after processing, and they should not be described as stem-cell treatments. They also should not be said to regrow cartilage or tissue, and no results can be promised.

Generally, no. Injectable amniotic products marketed for knee pain are not FDA-approved for that use, and the FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's regulatory status.

No, that claim is not established. Most processed amniotic products contain no living stem cells, and they should not be described as regrowing cartilage or tissue. A licensed clinician can explain what is and is not known.

Marketing often suggests it can, but these uses are generally not FDA-approved and results are not guaranteed. A doctor can evaluate the cause of your pain and discuss options with a known track record.

It varies, and only your provider can tell you what to expect for your situation. Ask what activity limits may apply, what side effects to watch for, and when to call the office.

Costs vary widely by clinic, and because these products are often not FDA-approved for joint or pain uses, insurance may not cover them. Ask for the total cost in writing and check with your insurer before treatment.

Ask whether the product is FDA-approved for your condition, where the tissue comes from, what the risks are, what alternatives exist, and what the total cost is. Also ask how your diagnosis was made and what else could be tried first.

Amniotic membrane wound healing refers to using donated, processed amniotic tissue as a covering on a wound while the body does its own repair. It is one of several options a licensed clinician may consider, usually alongside standard wound care. Whether it suits you depends on an evaluation.

Only a licensed clinician can decide that after examining you and your wound. An amniotic graft for a diabetic foot ulcer is typically considered alongside basics such as offloading, infection control and blood sugar management. Ask your provider about the product's FDA status, risks, alternatives and cost.

It may be considered in some cases, but it is not a guarantee. An amniotic graft for a venous leg ulcer is generally discussed alongside compression and other standard care. A provider can explain whether it fits your circumstances.

Skin substitutes for wounds are products placed over a wound to cover it and support its healing environment. They can be made from human tissue, animal tissue or synthetic materials. They differ in regulation and intended use, so ask your provider what a specific product is and how it is regulated.

Medicare skin substitute coverage depends on the product, the type of wound and the program's current rules, which can change. Coverage often has conditions attached. Ask your provider's office to check your coverage and any out-of-pocket responsibility before treatment begins.

Amniotic membrane has been used as a biologic covering for some burns under clinical supervision. Amniotic membrane burn treatment should only be directed by a licensed clinician, since burns can be serious. For a significant burn, call 911 or seek emergency care.

It is a way of describing skin, scar and hair care where amniotic-related products may come up in conversation. The established uses of amniotic membrane are as a wound covering and on the eye surface. Products promoted for skin or hair are generally not FDA-approved for those uses, so ask a provider about them.

Generally, no. Amniotic, umbilical cord, Wharton's jelly and exosome products are not FDA-approved for hair restoration, and the FDA has warned the public about unapproved regenerative products. A licensed provider can explain what options are established for your situation.

There is no promise that they can. Amniotic products are not FDA-approved for scar treatment or skin "regeneration," and most contain no living stem cells after processing. A dermatology provider can discuss scar care approaches that may fit you.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also check with your insurance before treatment. A trustworthy provider should answer these plainly.

Start by looking for a licensed provider with training and experience in your specific concern. Directories like Providers.plus list licensed providers, and you can ask about credentials and what a first visit involves.

Yes, stress may influence how skin and hair look and feel for some people, and it is one of many possible factors. A provider can help sort out which factors may be involved in your case. Supportive approaches like body-based or talk therapy may also be helpful alongside medical care.

Amniotic membrane is used as a biological covering on the eye surface, particularly the cornea, for certain injuries or surface conditions. It is an established use with a long history. Whether it fits your situation is a decision for your ophthalmologist after an exam.

Regulatory status depends on the specific product and how it is used, so ask your provider directly. Membrane used as a covering on the eye surface is the established use, while injectable amniotic products for other purposes are generally not FDA-approved. Your clinician can explain the status of any product they recommend.

It may be considered by some ophthalmologists for certain cases of eye surface disease, but it is not the right choice for everyone and results are never guaranteed. Many dry eye approaches exist, including drops and other measures. An evaluation helps determine what is appropriate.

Most processed amniotic membrane products contain no living stem cells, and they are not stem-cell treatments. They act as a tissue covering. Ask your provider about how a specific product is processed and its tissue source.

Ask about the product's FDA status, where the tissue comes from, the risks, the alternatives, and the total cost. Also ask what to expect during and after the visit. Check with your insurance before treatment.

See a doctor right away for sudden vision changes, severe pain, a chemical splash, or an eye injury. For emergencies, call 911 or go to emergency care. Do not wait for a routine appointment.

Amniotic membrane is sometimes used by oral surgery and dental providers as a biological covering over a surgical site in the mouth. Its established uses in medicine are as a wound covering and on the surface of the eye. Ask your provider how a specific product is regulated and why they would recommend it.

It depends on the specific product and how it is marketed, so ask your provider directly. Many amniotic tissue products are regulated differently from drugs, and the FDA has warned about unapproved regenerative products. Ask for the product's FDA status, tissue source, risks and alternatives.

A gum graft is a procedure in which a clinician places tissue to cover areas where the gum has pulled back from the tooth. The tissue may come from your own mouth or from a donor source. A periodontist or dentist can explain whether it might be considered in your case.

Healing time varies from person to person and depends on the tooth, the procedure and your overall health. Your dentist or oral surgeon can describe what to expect and what aftercare they recommend. Contact them if pain, swelling or bleeding seems to be getting worse instead of better.

Most processed amniotic products contain no living stem cells after processing. They should not be described as stem-cell treatments or as regrowing tissue. Ask your provider exactly what is in a product and where it comes from.

Look for a licensed dentist, periodontist or oral and maxillofacial surgeon who explains options clearly and answers your questions. You can use Providers.plus to find licensed providers. Ask about alternatives, the total cost and insurance coverage before treatment.

An orthopedics and sports medicine doctor evaluates and cares for problems of the bones, joints, tendons, ligaments and muscles. Some focus on non-surgical care and others perform surgery. They may help you understand what is causing your pain and what options exist.

No, amniotic injections for knee pain and other joint uses are generally not FDA-approved, and the FDA has warned the public about unapproved regenerative products. Amniotic membrane's established uses are as a wound covering and on the eye surface. Ask a provider about any product's regulatory status before considering it.

Generally no. Most amniotic products contain no living stem cells after processing, and they are not proven to regrow cartilage or other tissue. Be cautious of any claim suggesting otherwise.

Consider seeing one if pain, swelling or instability lasts, limits daily activities or keeps you from sport. Sudden severe injury, a deformed joint or inability to bear weight calls for urgent care or 911. A licensed clinician can advise on timing for your situation.

Ask whether the product is FDA-approved for your condition, where the tissue comes from, what the risks and alternatives are, and what the total cost will be. Also check with your insurance before treatment. A good provider will answer plainly and without pressure.

It depends on your diagnosis, and no one can promise that. Many conditions are first approached with non-surgical care, while others may need surgical repair. A licensed orthopedic provider can explain which paths may be reasonable after an evaluation.

Pain management is a medical specialty that evaluates and cares for ongoing or complex pain. A pain doctor may look at causes, daily function and a range of options, from non-procedural approaches to interventional care. What is appropriate is decided by a licensed clinician after an evaluation.

Interventional pain management refers to procedure-based care, such as injections near joints, nerves or the spine, often guided by imaging. It is one part of pain care and is not right for everyone. A doctor can explain whether any procedure fits your situation and what the risks are.

People often consider a pain specialist when pain lasts longer than expected, keeps returning, or limits daily life. A primary care clinician can help decide whether a referral makes sense. Seek urgent care right away for sudden severe pain, weakness or loss of bladder or bowel control.

Generally, no. Injectable amniotic, umbilical cord, Wharton's jelly and exosome products for pain or joints are not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Ask any provider about a product's FDA status, tissue source, risks, alternatives and total cost.

Most processed amniotic products contain no living stem cells, and they should not be described as regrowing cartilage or tissue. Amniotic membrane's established uses are as a wound covering and on the eye surface. Ask your provider to explain exactly what a product is and what is known about it.

Ask what may be causing your pain, what all your options are, and what the risks and limits of each are. Also ask about alternatives, how progress will be measured, and what the total cost would be. Check with your insurance before any procedure.

Physical medicine and rehabilitation (PM&R) is a medical specialty focused on restoring and improving function after injury, illness or long-term conditions. Its doctors, called physiatrists, often treat the muscles, bones, joints, nerves and spine. They look at how a problem affects your daily life, not just the body part involved.

A physiatrist is a doctor who evaluates problems affecting movement and function and helps coordinate care. They may examine you, order tests, recommend therapy, prescribe medications or perform certain procedures when appropriate. What they do depends on your situation and their clinical judgment.

People often seek one out for recovery after injury or surgery, trouble with mobility, or pain that lingers. A primary care clinician may also refer you. If you are unsure, a licensed provider can help you decide whether this specialty fits your needs.

No. Physical therapy is a profession that delivers hands-on and exercise-based care, while PM&R is a medical specialty practiced by physicians. The two often work together, and a physiatrist may refer you to a physical therapist as part of your care.

Generally no. Injectable amniotic, umbilical cord, Wharton's jelly and exosome products marketed for joint pain or 'regeneration' are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Amniotic membrane's established uses are as a wound covering and on the eye surface. Ask any provider about the product's FDA status, tissue source, risks, alternatives and total cost.

Bring a list of your symptoms, past injuries, medications, and any records or imaging you have. Write down your goals and questions, such as what you hope to do more easily. Also check with your insurance beforehand about coverage.

A podiatrist treats conditions of the foot, ankle and lower leg, such as heel pain, wounds, nail and skin problems, and structural concerns like bunions. What is appropriate for you depends on an evaluation by a licensed clinician.

Amniotic membrane is an established use as a wound covering, and it may be discussed as part of wound care for some foot ulcers. Whether it is appropriate for you is a decision for a licensed clinician after an evaluation, and you can ask about FDA status, risks, alternatives and total cost.

Generally no. Injectable amniotic, umbilical cord, Wharton's jelly and exosome products are not FDA-approved for heel pain or plantar fasciitis, and the FDA has warned the public about unapproved regenerative products. Ask any provider offering them about the product's regulatory status and your alternatives.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing, and they are not shown to regrow cartilage or tissue. Ask your provider exactly what is in a product and where it came from.

Plantar fasciitis is a common cause of heel pain, often noticed with the first steps after rest. It has traditionally been approached with conservative measures like stretching, supportive footwear and activity changes, guided by a clinician who has examined you.

Ask what is causing the problem, what the options and alternatives are, and what the risks are. If a product is suggested, ask about its FDA status and tissue source, the total cost, and whether your insurance covers it before you begin.

A regenerative medicine clinic is a practice that offers treatments marketed as supporting the body's natural repair processes, such as PRP or amniotic and umbilical cord products. Services and quality vary widely. A licensed clinician should evaluate you before recommending anything.

No, they are generally not accurately described that way. Most amniotic and umbilical cord products contain no living stem cells after processing. Ask a provider exactly what a product contains and where it comes from.

Amniotic membrane as a wound covering and on the eye surface is the established use. Injectable amniotic, umbilical cord and Wharton's jelly products for joints, pain or similar uses are generally not FDA-approved for those purposes. The FDA has warned the public about unapproved regenerative products, so ask any provider about a product's FDA status.

No one can promise that. Whether surgery is needed depends on your condition and a licensed clinician's evaluation. A provider can explain your options, their limits and the alternatives.

PRP stands for platelet-rich plasma, a preparation made from a person's own blood that is processed to concentrate platelets. It is used in some clinics for various concerns. Ask a provider how it is prepared, what is known about its use for your situation and what it may cost.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also check with your insurance before treatment. Be wary of any clinic that guarantees results or pressures you to decide quickly.

Spine care is the evaluation and care of the neck and back, including the discs, bones, joints and nerves. It may involve non-surgical approaches, surgery, or both, depending on what a licensed clinician finds. The goal of a visit is generally to understand your symptoms and discuss options.

Many people start with a primary care clinician, who may refer them to a spine specialist such as a physiatrist, pain medicine physician, orthopedic surgeon or neurosurgeon. The right choice depends on your symptoms and needs. Providers.plus can help you find licensed providers.

A spine evaluation generally includes a discussion of your history and symptoms and a physical exam of movement, strength and sensation. A clinician may recommend imaging or other tests if they think it is appropriate. You can then discuss possible next steps and ask questions.

No, surgery is not the path for everyone, and the decision belongs to you and a qualified clinician after an evaluation. Many people are first guided through non-surgical spine care. Ask your doctor about the risks, benefits and alternatives of any option.

Generally no. Injectable amniotic, umbilical cord, Wharton's jelly and exosome products are not FDA-approved for back pain or disc problems, and the FDA has warned the public about unapproved regenerative products. Amniotic membrane's established uses are as a wound covering and on the eye surface. If a provider suggests one, ask about its FDA status, tissue source, risks, alternatives and total cost.

Ask what may be causing your symptoms, what tests are needed and why, and what your options are, including non-surgical care. Also ask about risks, expected recovery, total cost and insurance coverage. Bringing notes about your symptoms can make the visit more useful.

Wound care is the assessment and management of wounds so they can heal safely, with extra attention to wounds that are slow to close. A licensed clinician looks at the wound and the health factors around it. Approaches vary by wound type and by person.

It is a wound covering made from donated amniotic tissue, the thin membrane from the placenta, that has been processed for clinical use. Using amniotic membrane as a wound covering is the most established use of amniotic tissue. Whether it fits a particular wound is a decision for a licensed clinician after an evaluation.

No, skin substitutes are a broad category that includes many different products, and amniotic membrane products are only some of them. Each product has its own regulatory status and intended use. Ask your provider how the specific product is classified and what it is meant for.

Injectable amniotic, umbilical cord, Wharton's jelly and exosome products used for joints, pain, hair, skin or regeneration are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Most processed products also contain no living stem cells. Ask a provider about FDA status, tissue source, risks and alternatives.

Coverage varies and the rules for skin substitutes change over time, so there is no single answer. Ask the provider's office to check your insurance before treatment and to explain the total cost you may be responsible for. It also helps to ask what documentation your plan needs.

People often seek evaluation for slow-healing wounds, diabetic foot ulcers, venous leg ulcers and pressure injuries. A wound that is not improving, is getting larger, or shows signs of infection should be checked by a licensed clinician. In an emergency, call 911.

"Amniotic doctor" is not a formal medical specialty. It is a common search phrase for licensed clinicians, such as wound care or regenerative medicine providers, who may use or discuss amniotic-derived products. Ask any provider about their training and how they use these products.

Start by looking for licensed providers in wound care or regenerative medicine in your area, and confirm their credentials. A directory like Providers.plus can help you find licensed providers. Then ask about the specific products they offer and the FDA status of each.

Injectable amniotic products for joints, pain, hair, skin or regeneration are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Amniotic membrane used as a wound covering or on the eye surface is the established use. Ask your provider about the exact product's status.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing. Be cautious of claims that a product regrows cartilage or tissue, and ask the provider what the product actually contains.

Coverage varies by product, use and plan. Established uses may be treated differently than unapproved ones. Check with your insurance company before treatment, and ask the provider for the total cost in writing.

Ask about the product's FDA status, where the tissue comes from, the risks, the alternatives and the total cost. Also ask how the provider will evaluate whether it is appropriate for you. A trustworthy provider should welcome these questions.

An amniotic fluid injection is a product made from donated amniotic fluid or related tissue that is processed and injected, often marketed for joints, pain or skin. Most of these uses are not FDA-approved. A licensed provider can explain what a specific product is and how it is regulated.

Generally, no, injectable amniotic products are not FDA-approved for joint, pain, hair, skin or regeneration uses. The FDA has warned the public about unapproved regenerative products. Ask any provider about the exact product's FDA status before treatment.

Most do not contain living stem cells after processing, despite some marketing language. They should not be called stem-cell treatments. Ask the provider what the product actually contains and how it was processed.

There is no established proof that these injections regrow cartilage or other tissue, and no one can promise that. Claims of regeneration deserve careful questions. A licensed doctor can discuss options with established evidence and regulatory status.

Safety depends on the product, its source, how it is screened and processed, and your own health, so no blanket answer applies. Any injection carries possible risks. Ask a provider about risks, alternatives and what to watch for after treatment.

Costs vary and this page does not quote prices. Insurance often does not cover unapproved products, so check with your plan first. Ask the provider for the total cost, including visits and follow-up, in writing.

It is a thin wound covering made from donated amniotic membrane that a clinician may place on a diabetic foot ulcer. It is considered a type of skin substitute or biologic dressing. A licensed provider decides after an evaluation whether it is appropriate.

It depends on the specific product, because different grafts are regulated in different ways. Some are marketed under tissue rules rather than approved as drugs or devices for this use. Ask your provider about the product's exact FDA status.

Most processed amniotic grafts contain no living stem cells after preservation. They should not be described as stem-cell treatments. Ask your provider what the product contains and where the tissue comes from.

No one can promise that. Healing depends on many factors, including blood flow, infection, pressure on the foot and overall health. A graft is only one possible part of a broader plan from your care team.

Costs vary and cannot be given here. Ask the provider for the total expected cost and check with your insurance about coverage before treatment begins.

Wound care specialists and podiatrists commonly treat them, often alongside a primary care doctor or endocrinologist. You can find licensed providers through Providers.plus.

An amniotic graft for venous leg ulcer is a thin covering made from processed amniotic membrane that a clinician may place on a wound. It is one of several options some providers consider when a wound is slow to heal. Whether it is appropriate depends on your evaluation.

It depends on the specific product, because amniotic wound coverings are regulated in different ways. Amniotic membrane as a wound covering is an established use, but you should ask your provider about the exact product's FDA status. Injectable amniotic products are generally not FDA-approved for these uses.

Generally no. Most amniotic products have no living stem cells after processing, so they should not be described as stem-cell treatments. Ask your provider what the product contains and where the tissue comes from.

No one can promise that. Healing depends on many factors, including circulation, swelling control, infection, overall health and wound care. A provider can explain what may be realistic for you.

Many clinicians consider compression a core part of venous ulcer care, but your provider decides what suits you. Ask how any graft would fit with the rest of your care and what you would be asked to do at home.

Wound care specialists and podiatrists are among the licensed providers who treat leg and foot wounds. You can look for a provider through Providers.plus. Ask about their experience with venous ulcers, the product's FDA status, risks, alternatives, total cost, and insurance coverage before treatment.

Costs vary by provider, product, location and what the visit includes, so this page does not give a price. Ask any provider for the total cost in writing, including the product, visit, imaging and follow-up. Also check with your insurer, since coverage is often limited for unapproved uses.

Coverage is often limited or unavailable when a product is not FDA-approved for the use in question. Plans differ, so contact your insurer before treatment and ask the provider's office what they expect. Get any answers in writing where you can.

Generally, no. Injectable amniotic, umbilical cord, Wharton's jelly and exosome products for joint or pain uses are not FDA-approved for those purposes, and the FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's FDA status.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing. Be cautious of any clinic that says they regrow cartilage or tissue.

Differences can come from the product used, its source and processing, the provider's setting, whether imaging is included, and how many sessions are proposed. A higher or lower figure does not by itself tell you about quality or safety. Ask what is included and why.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also ask what happens if it does not help and whether insurance may cover any part. A licensed provider should be able to answer clearly after evaluating you.

No, injectable amniotic products for back pain are generally not FDA-approved for that use. The FDA has warned the public about unapproved regenerative products. Ask any provider about a product's regulatory status before treatment.

It is not possible to promise that it will. Because these products are generally not approved for back pain, you should ask your provider what evidence they rely on and what the risks and alternatives are.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing, and they should not be expected to regrow cartilage or tissue.

Ask whether the product is FDA-approved for your condition, where the tissue comes from, what the risks are, and what alternatives exist. Also ask for the total cost and check with your insurance beforehand.

Doctors in orthopedics and sports medicine, pain management, and spine care commonly evaluate back pain. A primary care clinician is also a common first stop and may refer you if needed.

No one can promise that. Whether surgery is needed depends on your specific condition, which only a licensed clinician can evaluate. Ask about all your options and their evidence.

Generally, no. Injectable amniotic, umbilical cord and Wharton's jelly products used for knee pain are not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's status.

It is typically made from donated amniotic fluid, membrane, umbilical cord or related tissue that has been processed. Ask the provider about the tissue source and how it was handled.

No, they should not be described that way. Most processed amniotic products contain no living stem cells by the time they are used. Be cautious of marketing that suggests otherwise.

There is no established basis to say that it does. These products should not be described as regrowing cartilage or tissue, and no result can be promised. A licensed clinician can explain what is and is not known.

No one can promise that. Whether surgery or another option is appropriate depends on your condition and is decided with a licensed clinician after an evaluation.

Ask about the product's FDA status, its tissue source, the risks, the alternatives, and the total cost. Also check with your insurance before treatment, since coverage may not apply to unapproved uses.

It is an injection of a product made from processed donated amniotic or placental tissue, offered by some clinics for knee pain. These products are generally not FDA-approved for knee osteoarthritis. A licensed clinician can explain what a specific product is and whether it is appropriate.

Generally, no. Amniotic membrane is established as a wound covering and for the eye surface, but injectable amniotic products for knee osteoarthritis are generally not FDA-approved for that use. The FDA has warned the public about unapproved regenerative products, so ask your provider about the product's status.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing. Be wary of any clinic that uses that label.

There is no established evidence that these injections regrow cartilage, and no result can be promised. Any claim of regrowth should be questioned and discussed with a licensed doctor.

No one can promise that. Whether surgery is needed depends on your knee and your health, and a licensed orthopedic or sports medicine doctor can discuss your options after an evaluation.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also check with your insurance before treatment, since unapproved products are often not covered.

It is an injection of a product made from processed donated amniotic tissue, placed in or near the shoulder by a clinician. These products are generally not FDA-approved for shoulder use. A licensed provider can explain what a specific product is and whether it makes sense for you.

Generally, no. Injectable amniotic products for shoulders and other joints are not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Ask your provider about the exact product's regulatory status before treatment.

Most processed amniotic products contain no living stem cells. Be wary of clinics that call them stem-cell treatments. Ask the provider what the product contains and how it was processed.

No, it should not be described that way. There is no promise that these products regrow cartilage, tendon or any tissue. A provider can discuss realistic expectations and established alternatives.

Orthopedic and sports medicine doctors, pain management specialists and spine care providers commonly evaluate shoulder pain. Because shoulder pain can sometimes come from the neck, a thorough evaluation can help. Providers.plus lists licensed providers you can explore.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also check with your insurance before treatment, since coverage may not apply. Take your time deciding and consider a second opinion.

Generally, no. Injectable amniotic and related products marketed for tendonitis or joint pain are not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Amniotic membrane is established as a wound covering and on the eye surface. Ask any provider about a product's exact FDA status.

Most do not contain living stem cells after processing. Calling them stem-cell treatments is generally inaccurate. Ask the provider what is actually in the product and where the tissue came from.

No one can promise that. Claims that these products regrow tendon, cartilage or other tissue are not supported by FDA approval for that purpose. A licensed clinician can explain what is and is not known.

Conservative care is traditionally the starting point. This often includes activity changes, rest, physical therapy and supportive devices, with other options considered based on an evaluation. A clinician decides what fits your situation.

Orthopedic and sports medicine doctors, pain management specialists, spine care providers and podiatrists commonly evaluate tendon problems, depending on the area affected. They may help identify the cause and discuss options. Providers.plus lists licensed providers you can explore.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also check your insurance before treatment. A good provider will answer plainly and will not promise results.

No, injectable amniotic products are generally not FDA-approved for plantar fasciitis. The FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's regulatory status.

It is an injection of a processed product made from donated amniotic tissue or fluid, placed near the painful area of the foot. Some clinics offer it, but it is not an established standard treatment for this condition. A licensed clinician can explain what is actually in a given product.

Most do not contain living stem cells after processing, despite some marketing. They should not be described as stem-cell treatments. Ask the provider exactly what the product contains and where it comes from.

There is no promise that it will. These products should not be described as regrowing tissue, and results vary from person to person. A doctor can explain what is and is not known.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also ask whether insurance covers it and what happens if it does not help. Checking coverage before treatment can prevent surprises.

Podiatrists, sports medicine physicians, orthopedists and pain management specialists commonly evaluate heel pain. A primary care doctor can also be a good starting point. The right fit depends on your symptoms and history.

There is no single typical recovery time, because it depends on the product, the area treated and your health. Your provider can explain what activity guidance to expect after your specific procedure. Be cautious of anyone who promises a fixed timeline or result.

Generally, no. Injectable amniotic and related products used for joints and pain are typically not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's status before deciding.

It depends on your provider's instructions, which can differ by area treated and individual circumstances. Some clinicians recommend limiting certain activities for a period, while others give different guidance. Ask for written instructions so you know what to follow.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing, and they are not shown to regrow cartilage or tissue. Ask the provider exactly what is in the product.

Ask your provider about possible risks such as pain, swelling, reactions or infection, and how the product's tissue source is screened. Every procedure has risks, and a clinician can explain them for your situation. Seek urgent care or call 911 if you notice signs of a serious problem.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also check with your insurance beforehand, since coverage may not apply. A licensed provider should be willing to answer all of these clearly.

Commonly discussed risks include infection, injection-site reactions, immune or allergic responses, and uncertainty about product quality and handling. Because many injectable products are unapproved for these uses, their risks and benefits are less well established. A licensed clinician can discuss how this applies to you.

Injectable amniotic products for joints, pain, hair or skin are generally not FDA-approved for those uses. Amniotic membrane as a wound covering and on the eye surface is the established use. Ask your provider about the specific product's FDA status.

Most do not contain living stem cells after processing. Calling them stem-cell treatments is generally misleading. Ask the provider exactly what is in the product and where it came from.

No, they should not be described as regrowing cartilage or tissue. Claims like that are not supported by FDA approval for these uses. Be cautious of any clinic that promises such results.

No one can promise that. Whether surgery is needed depends on your condition and an evaluation by a licensed clinician. Ask about all alternatives and a second opinion.

Ask about the product's FDA status, tissue source, risks, alternatives and total cost. Also check with your insurance before treatment. A trustworthy provider should answer clearly without pressure.

Reported concerns with injections in general include pain, swelling or redness at the site, infection, and allergic or other reactions. Because many amniotic injection products are not FDA-approved for joint or pain uses, less may be known about their risks. Ask a licensed provider about the specific product and your personal risk.

Generally, no, not for joints, pain, hair, skin or regeneration. Amniotic membrane as a wound covering and on the eye surface is the established use. The FDA has warned the public about unapproved regenerative products, so ask any provider about a product's status.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing. Be cautious if a clinic uses that language, and ask what the product actually contains.

There is no established basis to say they regrow cartilage or tissue, and no provider can promise it. Claims like this are one reason to ask about FDA status and to seek a second opinion.

Ask about the product's FDA status, where the tissue came from, the risks, the alternatives and the total cost. Also check with your insurance before treatment. A trustworthy provider should welcome these questions.

Contact your provider if you notice increasing pain, swelling, warmth, redness, fever or anything that worries you. For an emergency, such as trouble breathing or severe symptoms, call 911.

Cortisone is an FDA-approved corticosteroid drug used to reduce inflammation, while injectable amniotic products are made from donated tissue and are generally not FDA-approved for joint or pain uses. They differ in what they are, how they work and how well they are regulated. A licensed clinician can explain which, if either, fits your situation.

No one can say that an amniotic injection is better than cortisone. Cortisone has a long history of use and is FDA-approved, while injectable amniotic products are generally unapproved for these uses and results are not guaranteed. The right choice depends on your evaluation and is made with a licensed clinician.

Injectable amniotic products for joints, pain, hair, skin or regeneration are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Amniotic membrane as a wound covering and on the eye surface is the established use. Ask any provider about a product's exact FDA status.

Most amniotic injections contain no living stem cells after processing. Calling them stem-cell treatments is generally inaccurate. Ask your provider exactly what the product contains and where the tissue came from.

There is no promise that an amniotic injection will regrow cartilage or tissue, or that it will help you avoid surgery. Be cautious of any clinic that makes those claims. A licensed orthopedic or sports medicine doctor can discuss realistic options.

Ask about the product's FDA status, its tissue source if relevant, the possible risks, the alternatives and the total cost. Also check with your insurance before treatment. Asking these questions helps you make an informed decision with your provider.

An amniotic membrane allograft is a thin graft made from the inner lining of a donated placenta. It is screened, processed, and preserved before use. The word "allograft" means the tissue comes from another person.

Its established uses are as a covering for certain wounds and as a graft on the surface of the eye. A licensed clinician decides whether it is appropriate after an evaluation. Other uses, such as injections for joints or skin, are generally not FDA-approved.

No, it should not be described that way. Most amniotic products contain no living stem cells after processing. Be cautious if a provider uses that label or promises tissue regrowth.

It depends on the specific product and how it is being used, so ask your provider directly. Amniotic products used as wound coverings or on the eye surface are the established use, while injectable amniotic or cord-based products for joints, pain, hair, or skin are generally not FDA-approved. The FDA has warned the public about unapproved regenerative products.

Coverage varies by the product, the reason for use, and your plan. Check with your insurance company and ask the provider's office about the total cost before treatment. Do not assume that a treatment is covered.

Ask about the product's FDA status, where the tissue comes from, the possible risks, the alternatives, and the total cost. Also ask what follow-up looks like and what happens if it does not help. A good provider will welcome these questions.

Amniotic membrane burn treatment is the use of processed amniotic tissue as a biological covering over certain burn wounds. A clinician decides whether it fits a given burn. It is one of several wound-covering options and does not guarantee any result.

Amniotic membrane as a wound covering is an established use, but regulatory status can differ from product to product. Ask your provider about the specific product's FDA status and what it is cleared or regulated for. Injectable amniotic products are generally not FDA-approved for burns or skin repair.

Most processed amniotic membrane products contain no living stem cells after processing. They should not be described as stem-cell treatments. Ask your provider exactly what the product contains and how it was prepared.

No one can promise that amniotic membrane will regrow skin or tissue. It is generally used as a protective covering while the body heals on its own. Your clinician can explain what it may and may not do in your case.

Burn specialists, surgeons and wound care providers may use it, and podiatrists may use similar wound coverings for foot wounds. The right provider depends on the burn's size, depth and location. You can search licensed providers through Providers.plus.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also check with your insurance before treatment. Asking these questions helps you make informed choices with your provider.

It refers to using a thin piece of processed amniotic tissue as a covering on the eye surface when a corneal ulcer is slow to heal. It is one option eye doctors may consider and is usually part of a broader plan. Whether it fits your case is decided by a licensed eye doctor.

Amniotic membrane used as a covering on the eye surface is an established use, but specific products differ in how they are regulated. Ask your provider about the FDA status of the exact product they would use. This is different from injectable amniotic products for joints or skin, which are generally not FDA-approved for those uses.

No one can promise a cure. Amniotic membrane may support the eye surface as part of care, but the cause of the ulcer, such as an infection, still needs to be evaluated and addressed by a clinician. Results vary by person.

Most processed amniotic membrane products contain no living stem cells. It is best understood as a biological tissue covering, not a stem-cell treatment. Your doctor can tell you how a specific product was processed.

This is typically an ophthalmologist, often one with cornea or external disease training. You can find licensed providers through directories such as Providers.plus. Ask about their experience with eye surface conditions.

Ask what is causing the ulcer, whether this option is right for you, and what the alternatives are. Also ask about the product's FDA status, tissue source, risks, recovery, and total cost. Check with your insurance before treatment.

Amniotic membrane dental treatment generally refers to a dentist or oral surgeon using processed amniotic membrane tissue as a covering at a surgical site in the mouth. It is not a single standardized procedure, and whether it is appropriate is up to a licensed clinician after an evaluation.

It depends on the specific product and its intended use, so you should ask your provider directly. Amniotic membrane as a wound covering and on the eye surface is the established use, while many other uses, especially injectable products, are generally not FDA-approved. The FDA has warned the public about unapproved regenerative products.

No, it should not be understood as regrowing gum, bone or teeth. Most processed amniotic products contain no living stem cells, and results are never guaranteed. A provider can explain what a given product is actually intended to do.

Safety depends on the product, how the tissue was screened and processed, and your own health. Like any dental procedure, it carries potential risks. Ask your provider about the tissue source, risks and alternatives before deciding.

Costs vary widely and this page cannot quote them. Ask your provider for the total cost, including the product, the procedure and follow-up visits. Check with your insurance beforehand, since newer or unapproved uses are often not covered.

A licensed dentist, periodontist or oral surgeon is the right starting point. Bring your questions about FDA status, tissue source, risks, alternatives and cost, and consider a second opinion if you are unsure.

It is a thin, processed tissue from the placenta that an eye doctor may place on the surface of the eye to protect and support it. It is generally considered for more significant surface problems rather than mild dryness. Only a licensed eye doctor can say whether it fits your situation.

It depends on the specific product and how it is used. Amniotic membrane on the eye surface is an established use, but products differ in their regulatory status. Ask your provider about the FDA status of the exact product they would use.

No one can promise a cure. Dry eye often has several causes and is frequently managed over time. An ophthalmologist may use amniotic membrane as one tool, and results vary from person to person.

No. Most processed amniotic products contain no living stem cells, and they should not be described as stem cell treatments. Ask your provider how the product is processed and what it actually contains.

It is typically provided by an ophthalmologist, a medical doctor who specializes in eye care. Some practices focus on the cornea and eye surface. You can use Providers.plus to find licensed providers and then ask about their experience.

Ask about the product's FDA status, where the tissue comes from, the risks, the alternatives, and the total cost. Also check with your insurance beforehand. A good provider will welcome these questions.

An amniotic membrane gum graft is a procedure in which a provider places a thin sheet of processed amniotic tissue over a treated area of the gums. Amniotic membrane is well established as a wound covering, but its use in gum surgery varies by provider. Ask whether it is right for your situation.

Not necessarily. Amniotic tissue is established as a wound covering and for the eye surface, but a specific product may not be FDA-approved for gum recession. Ask your provider about the product's exact FDA status and intended use before treatment.

Generally no. Most amniotic products contain no living stem cells after processing, so they should not be described as stem-cell treatments. Ask your provider what the product contains and how it is made.

A traditional graft often uses tissue taken from the patient's own mouth, while an amniotic membrane graft uses donated, processed tissue. Each has different considerations, and providers have different preferences. A periodontist or oral surgeon can explain the tradeoffs for your case.

No one can promise that. Results depend on the cause of the recession, your overall oral health and the provider's evaluation. A licensed dentist or periodontist can explain what is realistic and what other options exist.

Ask about the product's FDA status, tissue source, risks, alternatives and total cost. It also helps to ask what recovery and follow-up involve, and to check with your insurance beforehand. A second opinion is always reasonable.

The established amniotic membrane uses are as a covering for certain wounds and as a membrane placed on the surface of the eye. Other uses are marketed, but many are not FDA-approved. A licensed provider can explain which applies to you.

It depends on the product and the use. Some amniotic membrane products are used as wound coverings or on the eye under FDA rules, while injectable products for joints, pain or regeneration are generally not FDA-approved for those uses. Ask your provider about the specific product's status.

It comes from the inner lining of the amniotic sac, usually donated after a planned cesarean birth. Tissue banks screen, process and preserve it before clinics use it. Ask your provider about the tissue source of any product.

No, they should not be described that way. Most processed amniotic products contain no living stem cells by the time they are used. Be cautious of marketing that suggests they regrow tissue or cartilage.

Safety and effectiveness for joint pain have not been established to the level of FDA approval, and the FDA has warned the public about unapproved regenerative products. Talk with a licensed provider about risks, alternatives and total cost before considering one.

Wound care clinicians and eye specialists most often use it for the established purposes. Some regenerative medicine clinics also offer amniotic products. Ask any provider about their training, the product's FDA status and whether insurance may cover it.

Amniotic membrane wound healing refers to using a thin tissue from the placenta's inner layer as a covering on certain wounds. It is considered a type of skin substitute or biologic dressing. Whether it is appropriate depends on the wound and the person, and a licensed clinician makes that decision.

It depends on the specific product, because regulatory status varies. Using amniotic membrane as a wound covering is the established use, but not every product is regulated the same way. Ask your provider about the exact product's FDA status.

Most amniotic products contain no living stem cells after processing. They should not be described as stem-cell treatments. If a provider or marketer says otherwise, ask for clear documentation.

It has traditionally been considered for some chronic or slow-healing wounds, such as certain foot ulcers, and for burns. A wound care specialist or podiatrist can explain whether it fits your situation. It is often discussed alongside standard wound care.

No one can promise that. Outcomes vary, and the right path is decided by a licensed clinician after an evaluation. Ask your provider about the alternatives and what to expect.

Ask about the product's FDA status, where the tissue comes from, the risks, the alternatives and the total cost. Also check with your insurance before treatment. A good provider will welcome these questions.

The amniotic stem cell myth is the idea that amniotic injections are stem cell treatments that regrow cartilage or tissue. In many products, processing leaves no living stem cells, and such uses are generally not FDA-approved. Ask a provider what a specific product actually contains.

Often they do not. Many amniotic products are processed in ways that remove or inactivate living cells. A provider should be able to tell you the tissue source and what the product contains.

Injectable amniotic and umbilical cord products for joints, pain, hair, skin, or regeneration are generally not FDA-approved for those uses. The FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's status.

Amniotic membrane as a wound covering and on the eye surface is the established use. These are different from injectable products marketed for joints or cosmetic goals.

No one can promise that. Claims that amniotic products regrow cartilage or tissue are not supported by FDA approval, and you should be cautious of such promises. A licensed clinician can talk with you about realistic options.

Ask about the product's FDA status, its tissue source, the risks, the alternatives, and the total cost. Also check with your insurance before treatment. A trustworthy provider should welcome these questions.

Amniotic tissue donation is when a mother consents to give the amniotic membrane from her delivery for healthcare or research use instead of it being discarded. The tissue is screened, processed and distributed by a tissue processor. It is a voluntary choice made with your birth care team.

Donation takes place after the baby is born and uses tissue that would otherwise be discarded, so it is not meant to change the birth itself. Your care team can explain what is involved in your situation. Ask them any questions about your own health or delivery plans.

No, not everyone qualifies. Donors are usually screened for health history and infectious disease, and not every hospital runs a donation program. Your obstetrician or birth hospital can tell you whether donation is available and whether you may be eligible.

The established uses are as a wound covering and on the surface of the eye. Donated tissue is also used in research. Other uses, such as injections for joints, pain, hair or skin, are generally not FDA-approved, so ask a provider about the status of any product.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing. The FDA has warned the public about unapproved regenerative products, so ask a provider about a product's FDA status, tissue source and risks.

Ask whether the product is FDA-approved for the intended use, where the tissue came from and how it was processed. Also ask about risks, alternatives and the total cost, and check your insurance before treatment. A licensed clinician decides what is appropriate after an evaluation.

Amniotic products come from donated birth tissue, while PRP is made from your own blood. Amniotic membrane is well established as a wound covering and on the eye surface, but injectable amniotic products are generally not FDA-approved for joints, hair or skin. A licensed provider can explain how each applies to your situation.

There is no one answer, and only a licensed clinician can say what is appropriate after an evaluation. Neither is guaranteed to work, and injectable amniotic products for joints are generally not FDA-approved for that use. Ask a provider about alternatives, risks and the evidence for your specific concern.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing. If a clinic uses that language, ask for clarity on what the product contains and its FDA status.

The devices used to prepare PRP are regulated, but many specific uses of PRP, such as for joints, hair or skin, are considered off-label. Ask your provider how the use they suggest is classified and what that means for you.

No one can promise that. Whether surgery is needed depends on your condition and your clinician's evaluation. Be cautious of any provider who guarantees you will avoid surgery.

Ask about the product's FDA status, where the tissue or material comes from, the risks, the alternatives and the total cost. Also check with your insurance first, as these services are often not covered. A good provider should welcome these questions.

Amniotic injections use products made from donated pregnancy-related tissue or fluid, while stem cell injections generally use cells from a person's own body or another source. Despite the marketing, most processed amniotic products contain no living stem cells. Both categories are largely unapproved by the FDA for joint, pain, skin or hair uses, so ask a licensed provider about each product's status.

No, they should not be called stem cell treatments in most cases. After processing, most amniotic products do not contain living stem cells. If a clinic describes a product this way, ask for the product's tissue source and what it actually contains.

Generally not for joint pain, hair, skin or regeneration uses. Amniotic membrane has an established role as a wound covering and on the eye surface, but injectable products for other purposes are mostly unapproved, and the FDA has warned the public about unapproved regenerative products. Ask your provider directly about a product's FDA status.

There is no guarantee that either one can regrow cartilage or other tissue, and claims of this kind should be approached with caution. Regenerative products are still being studied, and many uses remain unproven. A licensed clinician can explain what is and is not known for your situation.

No one can promise that. Whether surgery is needed depends on your condition, exam and imaging, which a licensed clinician evaluates. Be wary of any provider who guarantees you can avoid surgery.

Ask whether the product is FDA-approved for your condition, where the tissue comes from, what the risks are, what the alternatives are, and what the total cost will be. Also check with your insurance beforehand. A trustworthy provider should answer these questions clearly and without pressure.

Generally, no. Exosome products marketed for joints, pain, hair, skin or regeneration are not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products. Ask any provider about the specific product's regulatory status.

Yes, the FDA has issued public warnings about unapproved regenerative medicine products, including some marketed as exosomes. You can read its consumer information on its website. It is also wise to ask a provider what they know about the product they offer.

No. Exosomes are tiny particles released by cells, not cells themselves. Most processed exosome or amniotic products contain no living stem cells, so they should not be described as stem-cell treatments.

Safety depends on the product, how it is made and how it is used, and unapproved products have not gone through FDA review for these uses. Risks may include infection or reactions. A licensed clinician can explain the possible risks for your situation.

Ask whether the product is FDA-approved for your condition, where the tissue comes from, and what the risks and alternatives are. Also ask about the total cost and whether insurance covers any of it. Asking for these answers in writing can help.

Coverage for exosome products is often limited because they are generally not FDA-approved for these uses. Check with your insurance company before treatment. Ask the provider's office about the total cost, too.

The FDA amniotic products warning is a public caution about unapproved regenerative products, including some made from amniotic or umbilical cord tissue. The concern is mainly about injectable products marketed for joints, pain, hair, skin or 'regeneration' without FDA approval for those uses. Ask a licensed provider about any specific product's status.

Generally, no. Injectable amniotic products promoted for joints, pain or similar uses are not FDA-approved for those purposes. Regulatory status can differ by product, so ask your provider to explain exactly what the product is and how it is regulated.

Yes. Amniotic membrane as a wound covering and on the surface of the eye is the established use. That differs from injectable products marketed for orthopedic, pain or cosmetic purposes.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing. Be cautious if a clinic says a product will regrow cartilage or tissue.

Ask about the product's FDA status, its tissue source, the risks, the alternatives and the total cost. Also ask what evidence supports its use for your situation. Check with your insurance before treatment, since coverage may be limited.

A licensed clinician, such as an orthopedic or sports medicine doctor or a regenerative medicine clinic, can evaluate your situation and explain your options. You can look for licensed providers through Providers.plus. A second opinion is always reasonable.

Amniotic products are generally made from donated birth tissue that is screened, recovered, cleaned, and then cut, ground, or concentrated depending on the product. It is usually preserved by drying, freezing, or freeze-drying and then packaged. Exact steps vary by manufacturer, so ask a provider about the specific product.

Amniotic tissue is typically donated by mothers who consent, most often after a planned cesarean birth. The tissue would otherwise be discarded. Donors are generally screened and tested for infectious disease.

Usually not. After processing and preservation, most amniotic products contain no living stem cells, so it is not accurate to call them stem-cell treatments. Ask your provider exactly what a product contains.

Injectable amniotic, umbilical cord, Wharton's jelly, and exosome products for joints, pain, hair, skin, or regeneration are generally not FDA-approved for those uses. The FDA has warned the public about unapproved regenerative products. Ask your provider about a product's regulatory status before treatment.

The established use is as a protective covering for wounds and on the surface of the eye. A clinician decides whether it is appropriate after an evaluation. Other uses are less established.

Ask about the FDA status, the tissue source, how it was screened and processed, whether it contains living cells, the risks, the alternatives, and the total cost. Also check with your insurance beforehand. A good provider should answer clearly.

In general, no. Injectable amniotic products marketed for joints, pain, hair, skin or regeneration are not FDA-approved for those uses. Amniotic membrane as a wound covering and on the eye surface is the established use. Ask your provider about the specific product's status.

Yes. The FDA has warned the public about unapproved regenerative medicine products, including some made from amniotic and umbilical cord tissue. It's wise to ask any clinic how a product is regulated before agreeing to treatment.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing, and they should not be said to regrow cartilage or other tissue.

Amniotic membrane has an established use as a wound covering and on the surface of the eye. These uses differ from injections, and regulatory details can vary by product, so a provider can clarify what applies.

Often not when the use is unapproved, but coverage varies by plan and situation. Check with your insurer and ask the provider for the total cost before treatment.

Ask about the product's FDA status, its tissue source, the possible risks, the alternatives and the total cost. Also ask whether it is part of a clinical study. A licensed clinician decides what is appropriate after an evaluation.

Sometimes, but it depends on the specific product, the type of wound, the care setting, and Medicare's current rules. Coverage is not automatic, and it is not the same for every product. Ask your provider's office to check coverage with Medicare or your plan before treatment.

It is generally based on factors such as the product's regulatory status, the kind of wound, and whether standard wound care has already been tried. Documentation from your provider usually plays a role as well. Specific requirements can vary by region and change over time.

It depends on the product and the use. Amniotic membrane as a wound covering is an established use, but regulatory status differs from product to product. Injectable amniotic products for joints, pain or cosmetic uses are generally not FDA-approved for those purposes, so ask your provider about a product's FDA status.

A licensed clinician, such as a wound care specialist or podiatrist, can decide after evaluating you. They can look at your wound, health history, and what has already been tried. No website can make that decision for you.

Ask about the product's FDA status, its tissue source, the possible risks, the alternatives, and the total cost to you. Also ask whether coverage has been confirmed with Medicare or your plan before treatment. Getting answers in writing can be helpful.

Generally not, because these products are typically not FDA-approved for joint pain and the FDA has warned the public about unapproved regenerative products. Coverage is often unavailable for uses that are not approved. Ask your provider about the status, risks, alternatives, and total cost, and check with Medicare before treatment.

Ask whether the product is FDA-approved for the use being offered, and what its regulatory status is. Also ask where the tissue comes from, whether it contains living cells, what the risks are, what the alternatives are, and what the total cost will be. It also helps to ask how success is measured and what happens if it doesn't help.

Injectable amniotic products for joints, pain, hair, skin or 'regeneration' are generally not FDA-approved for those uses. The FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's status and what that means for you.

No, they shouldn't be described that way. Most amniotic products contain no living stem cells after processing. If a clinic uses that term, ask them to explain exactly what is in the product.

Any injection can carry risks, and unapproved products may have less established safety information. Your provider should explain the possible risks that apply to you after an evaluation. Ask them to put that information in writing if you can.

Coverage often depends on the plan, and many insurers don't cover products that aren't FDA-approved for the intended use. Contact your insurance company before treatment. Also ask the provider for the total cost, including follow-up visits.

A licensed provider such as an orthopedic or sports medicine doctor or a regenerative medicine clinician can evaluate your situation and talk through your options. Consider a second opinion before deciding. You can use Providers.plus to find licensed providers.

A regenerative medicine doctor evaluates your concern and discusses options that may include conventional care and, in some cases, newer biologic approaches. What they offer varies widely by clinic and training. A licensed clinician decides what is appropriate for you after an evaluation.

Start by looking for licensed providers, such as orthopedic and sports medicine doctors, dermatology and aesthetics providers, or regenerative medicine clinics, through a directory like Providers.plus. Check their credentials and training, and read how they describe their services. Consider a consultation with more than one provider to compare.

Generally, no, injectable amniotic products are not FDA-approved for joint, pain, hair or skin uses, and the FDA has warned the public about unapproved regenerative products. Amniotic membrane used as a wound covering and on the eye surface is the established use. Ask your provider about the specific product's FDA status.

No. Most amniotic products contain no living stem cells after processing, so calling them stem-cell treatments is not accurate. They also should not be described as regrowing cartilage or tissue.

Ask about the product's FDA status, where the tissue came from, the possible risks, and the alternatives, including conventional options. Also ask for the total cost and check with your insurance before treatment. A trustworthy provider should answer these questions clearly.

No one can promise that. Whether any option may be appropriate depends on your condition and a licensed clinician's evaluation. Be cautious of any provider who guarantees you can avoid surgery or promises specific results.

Skin substitutes for wounds are materials, made from human tissue, animal tissue, lab-made components or a mix, that are placed on a wound to cover and protect it while the body heals. They are not all alike. A licensed clinician can explain which type, if any, may fit your situation.

It depends on the product and its use. Amniotic membrane used as a wound covering is an established use, but regulatory status varies by product. Injectable amniotic products for joints, pain or "regeneration" are generally not FDA-approved for those uses, so ask your provider about the specific product's status.

Most amniotic-based products contain no living stem cells after processing, and they should not be described as stem-cell treatments. Ask your provider exactly what the product contains and how it was processed.

They are typically applied by licensed clinicians such as wound care physicians, podiatrists or other trained providers. Availability depends on the clinic and the type of wound. You can ask about a provider's training and experience with these products.

There is no guarantee. A skin substitute may help support healing for some wounds, but results vary with the wound, overall health, circulation and other factors. A provider can discuss realistic expectations after an evaluation.

Coverage varies by plan, product and wound type, so check with your insurer before treatment. Ask the provider's office for the total expected cost and what documentation your plan may require.

Tissue bank accreditation is a review by an outside professional body that checks whether a tissue bank follows published standards for donor screening, processing, storage, labeling and tracking. It is a quality signal about the facility. It does not guarantee that a product will work or that it is approved for a particular use.

No. Accreditation is a voluntary review of a facility, while the FDA regulates human tissue products and the establishments that handle them. A product from an accredited bank may still not be FDA-approved for a given use, so ask your provider about that product's specific status.

It may offer some reassurance about how donor tissue was screened, handled and tracked. It does not make an unapproved use approved. Amniotic membrane as a wound covering and on the eye surface is the established use, while injectable products for joints, pain or hair are generally not FDA-approved.

Ask the provider directly for the name of the tissue bank and the product's source, and ask how you can verify its accreditation and FDA registration. A trustworthy provider should be willing to explain. You can also look up the accrediting body and FDA information on your own.

No, they should not be described that way. Most amniotic products contain no living stem cells after processing, and they are not shown to regrow cartilage or tissue. Ask your provider what the product actually contains and what its FDA status is.

Ask about the product's FDA status, its tissue source and bank, the risks, the alternatives, and the total cost. Also check with your insurance before treatment. Only a licensed clinician can decide what is appropriate for you after an evaluation.

An umbilical cord tissue injection is a preparation made from donated umbilical cord tissue, sometimes including Wharton's jelly, that a clinician injects. Processing varies by supplier, and most products contain no living stem cells. Ask a provider exactly what a specific product is.

For joint pain, hair, skin and 'regeneration' uses, these injections are generally not FDA-approved. The FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's FDA status.

No, they should not be described that way. Most processed cord tissue products contain no living stem cells by the time they are used. Ask the provider what the product actually contains.

There is no established basis to say they regrow cartilage or other tissue, and no provider can promise that. Be cautious about any clinic that makes such claims. A licensed clinician can explain what is and is not known.

As with any injection, possible risks can include pain, swelling, infection or a reaction, and unapproved products may have less-known risks. A provider can explain the risks that apply to you. Ask about them before deciding.

Ask about the product's FDA status, its tissue source, how it is processed, the risks, the alternatives and the total cost. Also check your insurance before treatment. A trustworthy provider should welcome these questions.

A Wharton's jelly injection is an injectable product made from the gel-like tissue inside the umbilical cord. It is often marketed for joint pain or 'regeneration.' These products are generally not FDA-approved for those uses, so it is wise to ask a licensed provider about the product's status.

Injectable Wharton's jelly products promoted for joints, pain, hair, skin or regeneration are generally not FDA-approved for those uses. The FDA has warned the public about unapproved regenerative products. Ask your provider about the specific product's FDA status before treatment.

Most do not contain living stem cells after processing. Calling them stem-cell treatments is generally not accurate. Ask the provider exactly what is in the product and how it was prepared.

There is no assurance that it can. Claims that these products regrow cartilage or other tissue should be viewed with caution. A licensed clinician can explain what is and is not known about your situation.

Ask about FDA status, the tissue source, risks, alternatives and the total cost. Also check with your insurance before treatment. A good provider will welcome these questions and give you time to decide.

Orthopedic and sports medicine doctors, regenerative medicine clinics, and dermatology and aesthetics providers may discuss these options. A licensed provider can evaluate your situation and explain established alternatives alongside any newer ones.

Amniotic tissue is the thin membrane that surrounds a baby in the womb and holds the amniotic fluid. In healthcare, donated and processed amniotic tissue is sometimes used as a biological covering. Only a licensed clinician can say whether it is appropriate for a given situation.

Donated amniotic tissue usually comes from consenting donors after a planned cesarean birth. It is screened, processed and preserved before use. You can ask a provider about the tissue source of any specific product.

No. Most amniotic products are processed and are not expected to contain living stem cells. Calling them stem-cell treatments is not accurate, so ask your provider what a product actually contains.

It depends on the product and the use. Amniotic membrane as a wound covering and on the eye surface is the established use. Injectable amniotic, cord, Wharton's jelly and exosome products for joints, pain, hair or skin are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products.

The established uses are as a covering for certain wounds and on the surface of the eye. Some clinics market other uses, but those are generally not FDA-approved. A licensed provider can explain what applies to you.

Ask about the product's FDA status for the proposed use, its tissue source, the risks, the alternatives and the total cost. Also check with your insurance before treatment. A good provider will answer plainly and will not promise results.

Most amniotic products come from tissue donated by mothers after a healthy, scheduled cesarean birth. The tissue is screened, processed and distributed by a tissue bank or manufacturer. Ask your provider about the specific source of any product they suggest.

No. Amniotic products come from tissues around a baby, such as the membrane, fluid or placenta, after birth. They are not made from an embryo. Ask the provider where a specific product's tissue came from.

Donation takes place after the baby is born, using tissue that would usually be discarded. The mother gives consent and is screened for health risks. Details vary by tissue bank, so a provider can explain what they know about their supplier.

Most do not contain living stem cells after processing, even if marketing suggests otherwise. They should not be described as stem-cell treatments. Ask the provider what is actually in a product and how it was processed.

It depends on the product and the use. Amniotic membrane as a wound covering and on the eye surface is the established use. Injectable products for joints, pain, hair, skin or regeneration are generally not FDA-approved for those uses, and the FDA has warned the public about unapproved regenerative products.

Ask about its FDA status for your use, tissue source, processing, risks, alternatives and total cost. Also check with your insurance before treatment. A licensed clinician can decide what is appropriate after evaluating you.